The company recently relocated to occupy over 2,000 square feet of the Northern Virginia Bioscience Center, where it will begin to develop new diagnostic technologies to M and quantify SARS-CoV-2, like the COVID-19 coronavirus, variants and other viral pathogens.
The expansion project will create up to 70 new jobs.
“Prince William County has emerged as a hub for the life sciences industry, offering the infrastructure, R&D assets, and talent to attract and retain innovative biotech firms like Virongy,” said Governor Youngkin. “We applaud the company for its groundbreaking developments that will have a positive and far-reaching impact on bioscience advancements and disease prevention and treatment.”
Virongy Biosciences Inc. was founded in 2014.
The Northern Virginia Bioscience Center, at 11225 Asset Loop near 2 Silos Brewing outside Manassas, opened April 1 at a cost of $17.5 million.
